Form 8-K - Current report:
SEC Accession No. 0001649094-25-000057
Filing Date
2025-05-01
Accepted
2025-05-01 08:16:04
Documents
13
Period of Report
2025-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pcvx-20250501.htm   iXBRL 8-K 27147
  Complete submission text file 0001649094-25-000057.txt   153948

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20250501.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20250501_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20250501_pre.xml EX-101.PRE 13046
15 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20250501_htm.xml XML 2811
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 25899607
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)